1. Home
  2. PICS vs TRAX Comparison

PICS vs TRAX Comparison

Compare PICS & TRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PicS N.V. Class A Common Shares

PICS

PicS N.V. Class A Common Shares

N/A

Current Price

$13.69

Market Cap

1.4B

Sector

Finance

ML Signal

N/A

TRAX

First Tracks Biotherapeutics Inc. Ordinary Shares

N/A

Current Price

$31.40

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PICS
TRAX
Founded
2012
2025
Country
Brazil
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2021
2026

Fundamental Metrics

Financial Performance
Metric
PICS
TRAX
Price
$13.69
$31.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
12
Target Price
$19.61
★ $70.58
AVG Volume (30 Days)
490.5K
★ 604.3K
Earning Date
08-24-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$48.94
N/A
Revenue Next Year
$38.31
N/A
P/E Ratio
$29.44
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.11
$15.69
52 Week High
$18.49
$49.91

Technical Indicators

Market Signals
Indicator
PICS
TRAX
Relative Strength Index (RSI) 72.20 35.27
Support Level $13.20 $15.69
Resistance Level $13.78 $48.94
Average True Range (ATR) 0.75 2.55
MACD 0.55 -0.43
Stochastic Oscillator 98.32 9.46

Price Performance

Historical Comparison
PICS
TRAX

About PICS PicS N.V. Class A Common Shares

PicS NV is a digital payments company. The company operates a peer-to-peer (P2P) transfer platform that enables individuals to send money via mobile devices. It provides digital wallets, instant payments (Pix), P2P transfers, credit cards, loans, investments, insurance, and SMB payment solutions. The company has four reportable segments: Consumer Banking, Small and Medium-Sized Businesses, Audiences and Ecosystem Integration, and Institutional. The majority of the company's revenue is derived from the Consumer Banking segment, which generates revenue from various transaction activities occurring in the digital wallet, such as Pix, peer-to-peer (P2P) transfers, and bill payments.

About TRAX First Tracks Biotherapeutics Inc. Ordinary Shares

First Tracks Biotherapeutics Inc is a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases. Its clinical-stage pipeline includes rosnilimab, a selective pathogenic T cell depleter, for which it completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA), ANB033, a CD122 antagonist, in a Phase 1b trial for celiac disease (CeD) and eosinophilic esophagitis (EoE), and ANB101, a BDCA2 modulator, in a Phase 1a trial. The company operates in one reportable segment focused on research and development activities to deliver immunology therapeutics for autoimmune and inflammatory diseases.

Share on Social Networks: